MGM insider notice — 60,000 common shares to be sold for $2.17M

Rhea-AI Filing Summary

Form 144 Notice: This filing notifies a proposed sale of 60,000 shares of common stock through Merrill (1800 K St NW, Washington DC) on or about 09/15/2025 with an aggregate market value of $2,167,159.81. The filing lists total shares outstanding as 272,191,042. The securities to be sold were acquired under the issuer's stock plan on multiple dates from 10/29/2021 through 04/01/2024, with individual lot sizes shown in the table. The filer reports "Nothing to Report" for securities sold in the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a planned sale of 60,000 common shares; disclosure appears complete and standard.

The filing shows a proposed brokered sale through Merrill of 60,000 common shares with an aggregate market value of $2,167,159.81, and lists cumulative grant/acquisition lots from the issuer stock plan between 2021 and 2024. The filer states no sales in the prior three months and affirms no undisclosed material adverse information. For investors, the filing is procedural disclosure of an intended insider or affiliate sale under Rule 144 rather than an operational update.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; the Form 144 documents planned disposition and standard attestation by the seller.

The document meets Rule 144 reporting elements: issuer and broker identification, class and quantity of shares to be sold, aggregate market value, outstanding shares, and acquisition history showing these shares originated from the issuer's stock plan. The remarks include the required seller representation regarding material information and the criminal-penalty notice. Impact on governance or control appears neutral based on the information provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 1800 K ST NW, Ste. 800 Washington DC 20006	60000	2167159.81	272191042	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/29/2021	Stock Plan	Issuer			149	10/29/2021	N/A
Common	11/14/2021	Stock Plan	Issuer			138	11/14/2021	N/A
Common	11/14/2021	Stock Plan	Issuer			97	11/14/2021	N/A
Common	02/27/2022	Stock Plan	Issuer			149	02/27/2022	N/A
Common	04/01/2022	Stock Plan	Issuer			2	04/01/2022	N/A
Common	08/18/2022	Stock Plan	Issuer			2980	08/18/2022	N/A
Common	08/18/2022	Stock Plan	Issuer			2	08/18/2022	N/A
Common	10/04/2022	Stock Plan	Issuer			2384	10/04/2022	N/A
Common	10/07/2022	Stock Plan	Issuer			6842	10/07/2022	N/A
Common	10/19/2022	Stock Plan	Issuer			2845	10/19/2022	N/A
Common	10/19/2022	Stock Plan	Issuer			108	10/19/2022	N/A
Common	04/01/2023	Stock Plan	Issuer			2	04/01/2023	N/A
Common	08/18/2023	Stock Plan	Issuer			15498	08/18/2023	N/A
Common	08/18/2023	Stock Plan	Issuer			19073	08/18/2023	N/A
Common	10/03/2023	Stock Plan	Issuer			4457	10/03/2023	N/A
Common	10/04/2023	Stock Plan	Issuer			2384	10/04/2023	N/A
Common	02/27/2024	Stock Plan	Issuer			149	02/27/2024	N/A
Common	04/01/2024	Stock Plan	Issuer			2741	04/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MGM Form 144 disclose about the planned sale?

The notice discloses a proposed sale of 60,000 common shares via Merrill on or about 09/15/2025 with an aggregate market value of $2,167,159.81.

How many shares outstanding does the MGM filing show?

The filing lists 272,191,042 shares outstanding.

Were any MGM shares sold by the filer in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

How were the shares to be sold acquired according to the MGM Form 144?

The securities were acquired under the issuer's stock plan across multiple dates from 10/29/2021 through 04/01/2024, with specific lot sizes listed in the filing.

Does the filer assert they possess any undisclosed material information?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.